Phase I results of Bavarian Nordic's novel pancreatic cancer therapy reported at ECCO 10 Sep. 28, 1999
Novel fluoro-2-pyridone antibiotics designed at Abbott; synthesis and SAR discussed at ICAAC Sep. 28, 1999
Paclitaxel/doxorubicin is superior to standard first-line therapy in metastatic breast cancer Sep. 28, 1999
RSS